Sao Tome and Principe vs Tunisia: HIV-positive TB patients on ART (antiretroviral therapy)
Sao Tome and Principe
100.0%
in 2024
Tunisia
100.0%
in 2023
Sao Tome and Principe rank
1st
Tunisia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sao Tome and Principe
- Tunisia
How they compare
Sao Tome and Principe currently reports 100.0% against 100.0% in Tunisia, a difference of 0.0%.
Across all 16 years both countries report, Tunisia has been ahead every year.
Sao Tome and Principe ranks 1st and Tunisia ranks 1st of 144 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sao Tome and Principe | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.0% | 100.0% | 66.0% | Tunisia |
| 2010s | 94.9% | 100.0% | 5.1% | Tunisia |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sao Tome and Principe or Tunisia?
- Sao Tome and Principe, at 100.0% against 100.0% in Tunisia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sao Tome and Principe and Tunisia?
- 0.0%, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Sao Tome and Principe and Tunisia?
- 16 years are reported by both, from 2007 to 2023.
- How do Sao Tome and Principe and Tunisia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sao Tome and Principe ranks 1st and Tunisia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.